Rights and permissions
About this article
Cite this article
Rifampicin exposure reduced in type 2 diabetes. Inpharma Wkly. 1556, 19 (2006). https://doi.org/10.2165/00128413-200615560-00047
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200615560-00047